ARCHIVES

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

This article is from The Cancer Letter archive.

Vol. 12 No. 05 | January 31, 1986

Download PDF Visit The Full Archive

Related Articles

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

Drug Development Gets Extra $500,000

November 18, 1977

In Brief: Three More Comprehensive Centers May Be Names; Hawaii, Cleveland, Ohio State Lead List of 10

May 9, 1975

New Screening Tool Helps GP ID Hereditary BC Risk

October 27, 2006

Firm’s Information System Embedded In iKnowMed For Treatment Outcomes.

June 29, 2001